A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort
This study is gathering vital information about a serious form of very high blood pressure known as malignant hypertension. Even though it's a severe condition that can be life-threatening if not treated, we still don't know enough about it today. This project, called the HAMA Cohort, plans to create the first large database of patients with this condition in the UK. By collecting information from many hospitals, researchers want to understand how common it is now, how doctors are currently treating it, and what happens to patients over time. The goal is to update how we define and diagnose malignant hypertension and eventually create better, evidence-based guidelines for treatment. This research is crucial because current knowledge and recommendations haven't changed much in decades, despite the condition affecting younger adults and having serious health consequences.
Överblick
Vad handlar denna studie om?
This study, called the HAMA Cohort, is looking into a very serious type of high blood pressure known as malignant hypertension. This isn't just slightly high blood pressure; it's when your blood pressure is extremely high (over 180/110) and is causing immediate damage to your body, particularly your eyes. If left untreated, it can be very dangerous.
Even though it's a severe condition, affecting people often between 35 and 55 years old, there hasn't been much research on it in recent times. This means that doctors are often relying on old information and general advice to treat it because there aren't many up-to-date guidelines based on solid scientific evidence. The aim of this study is to change that by gathering a lot of new information.
The researchers want to create the first big database of patients with malignant hypertension across many hospitals. By doing this, they hope to understand how common the condition is today, how it's being managed, and what happens to patients over several years. This new information will help them update the definition and diagnosis of malignant hypertension, understand its effects on different parts of the body, and ultimately develop much better, evidence-based recommendations for treatment to improve patient care.
Viktiga punkter
- This study focuses on malignant hypertension, a very severe form of high blood pressure.
- It aims to update our understanding and improve treatment recommendations.
- Participation involves sharing existing medical information; no new treatments are given.
- The study collects data over a 5-year period for each patient.
- Your contribution helps future patients with this condition.
Vem kan vara berättigad?
To be part of this study, you would need to have malignant hypertension. This usually means your blood pressure is very high (over 180/110 for the top number and over 110 for the bottom number) and doctors can see specific issues, such as severe changes in the back of your eyes (retinopathy) linked to high blood pressure. Alternatively, you might be eligible if you have very high blood pressure (over 180/110) along with acute damage to three different organs in your body caused by this high blood pressure.
You cannot join the study if you are under 18 years old. Also, if you are unable to freely agree to take part, or if you decide you don't wish to participate, you won't be included. Patients who are currently on dialysis treatment for kidney failure also cannot take part in this study.
Kan denna studie passa dig?
Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.
- Is your blood pressure very high (over 180/110)?
- Have doctors diagnosed you with severe eye problems (retinopathy) because of your high blood pressure?
- Or, do you have very high blood pressure causing acute damage to three different organs in your body?
- Är du 18 år eller äldre?
- Are you not currently receiving dialysis treatment for kidney failure?
Vad innebär deltagande?
This study is a 'registry,' which means it primarily involves collecting health information over time rather than giving new treatments. If you choose to take part, researchers will collect anonymous information from your medical records related to your malignant hypertension. This would include details about your diagnosis, how your condition is being managed, and how it progresses over the next five years. You won't be asked to take any new or different medications specifically for this study, nor will you have extra clinic visits beyond your usual medical care. The study aims to follow how your condition develops under your standard medical treatment, without changing anything about your care. The total duration of data collection for each patient is expected to be five years.
Potentiella risker och fördelar
Platser (37)
- CH d'AnnecyVerifierat postnummerAnnecy, France· Rekrytering
- CH de la côte BasqueVerifierat postnummerBayonne, Frankrike· Rekrytering
- Avicenne APHPVerifierat postnummerBobigny, Frankrike· Rekrytering
- CHU - Hôpital St AndréVerifierat postnummerBordeaux, Frankrike· Rekrytering
- CH de Chalon sur SaoneVerifierat postnummerChalon-sur-Saône, France· Rekrytering
- CH MétropoleVerifierat postnummerChambéry, Frankrike· Rekrytering
- CHU de Clermont FERRANDVerifierat postnummerClermont-Ferrand, Frankrike· Rekrytering
- Hôpital Henri MondorVerifierat postnummerCréteil, France· Rekrytering
- CH de DinardVerifierat postnummerDinard, France· Rekrytering
- CHU MichallonVerifierat postnummerGrenoble, Frankrike· Rekrytering
- hôpital de HaguenauVerifierat postnummerHaguenau, France· Rekrytering
- Pôle Santé SudVerifierat postnummerLe Mans, France· Rekrytering
Vanliga frågor
What is malignant hypertension?
It's a very severe form of high blood pressure where your blood pressure is extremely high and is causing damage to your body, especially your eyes or other organs.
Varför är denna forskning viktig?
There hasn't been much new research on malignant hypertension for a long time. This study aims to gather up-to-date information to improve diagnosis and treatment guidelines for patients.
Kommer jag att få ny behandling i denna studie?
No, this is a registry, meaning it collects information from your existing medical care. You will continue with your standard treatment as prescribed by your doctor.
Hur länge kommer jag att vara involverad i studien?
The study aims to collect information about your health over a five-year period.
Är mina personuppgifter säkra?
Yes, your information will be collected anonymously and kept strictly confidential. Your privacy is a priority.
Hur du får reda på mer
Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.
Intresserad av att delta?
Diskussion
Gemenskapsdiskussion
Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.